Eurofins CDMO Alphora Inc., a CDMO based in Mississauga, Canada, has successfully completed its pilot-scale biologics development facility. The 3,300 sq.-ft. facility is dedicated to the development and scaling of monoclonal antibodies (mAbs) and other mammalian-based therapeutic proteins. The facilities offer upstream and downstream development, process design, analytical development, GMP QC testing, GMP Cell-Based Assays, and scale-up capacity to 200L for preclinical and phase I supply. The...